Ben Potter advises private and public companies, venture capital, and private equity firms, as well as investment banks involved in the technology, life sciences, and other growth industries. He serves as Global Vice Chair of the Emerging Companies Practice and is the former Global Chair of the Technology Industry Group.

Mr. Potter provides clients timely hands-on support and leverages access to the full resources of the firm’s global platform. He draws on considerable legal insight and complementary prior experience at IBM Global Services and two education startup companies in New York City.

Mr. Potter provides clients with company representation on a full range of matters and transactions, including:

  • Public and private financing transactions
  • Mergers and acquisitions
  • Formation issues
  • Employment matters
  • Equity incentives
  • Securities law compliance
  • License agreements
  • Corporate governance matters

Mr. Potter’s representative clients include:

Technology

  • Adept
  • Agility Robotics
  • Area 1 Security
  • Bright Cellars
  • Bright Machines
  • Canva
  • Clarify Health
  • Codi
  • Convex
  • dbt Labs
  • Discord
  • Dolls Kill
  • Duolingo
  • Evernote
  • Expensify
  • Finite State
  • Fractal
  • GoFor
  • Grammarly
  • Headspace
  • HomeLight
  • Impossible Foods
  • Iron Ox
  • Joby Aviation
  • KoBold Metals
  • Light
  • Medallion
  • Memebox
  • Moonwalk
  • Mosaic
  • MotherDuck
  • Nobell Foods
  • Optimus Ride
  • Ouster
  • Owlet
  • Playtika
  • Puzzle
  • Rundoo
  • Skillz
  • Sleeper
  • Solvvy
  • Standard Metrics
  • Sunwink
  • Synack
  • Turvo
  • Upside Foods
  • Zeal
  • Zarta

Blockchain and Crypto

  • Aave
  • Aptos
  • Arpeggi
  • Astaria
  • Azra Games
  • Bitwise
  • Connext
  • Collective
  • Cymbal
  • Draup
  • Element
  • Flow Carbon
  • Halliday
  • Joyride
  • Mad Realities
  • Nillion
  • Nouns
  • OpenSea
  • Opyn
  • OrangeDAO
  • Paper.xyz
  • Staked
  • Star Atlas
  • Sup
  • Superdrop
  • Syndicate
  • Turnkey

Life Sciences and Medical Devices

  • 3T Biosciences
  • 4D Molecular Therapeutics
  • Afferent Pharmaceuticals
  • Coherus BioSciences
  • Corium
  • Crossover Health
  • Curai
  • Curasen Therapeutics
  • Genascence
  • Ideaya
  • Imago BioSciences
  • Innocoll Biotherapeutics
  • Moment Biosciences
  • Myome
  • Pionyr
  • PROCEPT BioRobotics
  • Tizona Therapeutics
  • Trishula Therapeutics

Venture Capital and Private Equity

  • 8VC
  • a16z
  • B-Flexion
  • Base10
  • BuildersVC
  • Coatue
  • Eclipse
  • EnergizeVC
  • General Catalyst
  • Gurnet Point Capital
  • KKR
  • Lightspeed
  • Meritech Capital Partners
  • Pantera
  • Paradigm
  • Sequoia
  • Silver Lake
  • Softbank
  • Variant

Bar Qualification

  • California

Education

  • JD, University of Michigan Law School, 2006
    cum laude
  • MBA, University of Michigan, 2006
  • BA in History, Yale University, 1998
    with Distinction